Pharmafile Logo

COUCH Medcomms

- PMLiVE

Takeda’s Fruzaqla receives FDA approval for metastatic colorectal cancer

More than 150,000 new cases of colorectal cancer will be diagnosed in the US in 2023

- PMLiVE

Valneva’s chikungunya vaccine approved by FDA for adults at increased exposure risk

The decision makes Ixchiq, which is administered as a single injection, the world's first licensed vaccine against the mosquito-borne disease

- PMLiVE

New £5m project launched to bring Alzheimer’s blood tests to the NHS

Blood tests for the condition could become available on the NHS within five years

- PMLiVE

NICE recommends Chiesi’s alpha-mannosidosis enzyme replacement therapy

Alpha-mannosidosis, an extremely rare inherited condition characterised by a broad range of impairments, affects approximately 25 people in England

- PMLiVE

UK antibiotic subscription model found by OHE as key to supporting investment

The OHE report offers valuable insights into investor views of the subscription model

- PMLiVE

Vaccitech renames as Barinthus Biotherapeutics to focus on immunotherapy

The clinical-stage biopharma said the new name represents the expansion of its efforts beyond vaccines

- PMLiVE

Focusing in on real-world evidence and its capabilities

The surge in real-world data presents opportunities for greater understanding of patients and conditions, but it needs standardising and harmonising to liberate its full potential

- PMLiVE

PM Society announces new chair for 2024

Dom Marchant, chief creative officer at OPEN Health, has been part of the PM Society executive team for seven years

- PMLiVE

Changing What’s Possible for Women in Healthcare

Career choices are driven by many factors. In medicine, doctors are often drawn to a particular specialty following a personal experience.That’s the case with both of the renowned speakers in...

Medscape Education

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

OPEN Health

OPEN Health at ISPOR Europe

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

OPEN Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links